Search results
Chemo Before, After Surgery Could Help Those Battling Esophageal Cancer | FOX 28 Spokane
FOX 28 Spokane· 3 hours agoPeople battling advanced esophageal cancers should get doses of chemotherapy both before and after...
GSK’s Jemperli shows potential in Phase II trial for locally advanced rectal cancer
Clinical Trials Arena via Yahoo Finance· 2 hours agoThe drug is not currently approved for the frontline treatment of locally advanced dMMR rectal...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 16 hours agoMelanoma patients who received monthly mRNA vaccines and Merck’s Keytruda immunotherapy had lower...
EMA CHMP recommends AstraZeneca’s Tagrisso for lung cancer
Pharmaceutical Technology via Yahoo Finance· 3 hours agoThe committee’s positive opinion is based on results from the open-label, randomised, multicentre,...
NHS launches personalised mRNA cancer vaccines trial
Clinical Trials Arena via Yahoo Finance· 4 days agoThe NHS has commenced a clinical trial offering personalised cancer vaccines being developed by BioNTech and Genentech to patients. The first patient was...
FibroGen To Begin Trials on Tumor Treatment After FDA OK
Morningstar· 15 hours agoFibroGen can begin conducting clinical trials for its potential solid tumor treatment after regulators approved the company's application. The San Francisco-based company said Monday that the ...
Analyst Report: IQVIA Holdings Inc.
Morningstar Research via Yahoo Finance· 13 hours agoIQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development ...
Ivonescimab Manuscript for HARMONi-A Clinical Trial Results Published in JAMA
Morningstar· 3 days agoThe publication is based on the results of HARMONi-A, a single region, multi-center, Phase III study conducted in China sponsored by Akeso, Inc. (Akeso, HKEX Code...
Indaptus reports positive Phase 1 trial results for cancer treatment By Investing.com
Investing.com· 17 hours agoIndaptus Therapeutics, Inc. (NASDAQ: INDP), a biotechnology firm focused on developing therapies for...
Takeda's TAK-861 shows promise in narcolepsy trial By Investing.com
Investing.com· 18 hours agoOSAKA, Japan & CAMBRIDGE, Mass. - Takeda Pharmaceutical Company (NYSE:TAK) Limited (TSE:...